The price of Biora Therapeutics Inc (NASDAQ: BIOR) closed at $1.17 in the last session, down -12.03% from day before closing price of $1.33. In other words, the price has decreased by -$0.1600 from its previous closing price. On the day, 598168 shares were traded.
Ratios:
We take a closer look at BIOR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.28 and its Current Ratio is at 0.30.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOR now has a Market Capitalization of 31.83M and an Enterprise Value of 101.66M. Its current Enterprise Value per Revenue stands at 5.65k whereas that against EBITDA is -0.92.
Stock Price History:
Over the past 52 weeks, BIOR has reached a high of $6.70, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 1.0399, while the 200-Day Moving Average is calculated to be 2.1392.
Shares Statistics:
According to the various share statistics, BIOR traded on average about 393.03K shares per day over the past 3-months and 289.41k shares per day over the past 10 days. A total of 27.21M shares are outstanding, with a floating share count of 24.50M. Insiders hold about 9.96% of the company’s shares, while institutions hold 47.69% stake in the company. Shares short for BIOR as of Feb 29, 2024 were 1.13M with a Short Ratio of 3.01, compared to 638.29k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.14% and a Short% of Float of 4.40%.
Earnings Estimates
The company has 0 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$1.64. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$1 and -$3.11 for the fiscal current year, implying an average EPS of -$2.05. EPS for the following year is -$2, with 2 analysts recommending between -$0.93 and -$3.08.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for BIOR’s current fiscal year. The highest revenue estimate was $6M, while the lowest revenue estimate was $3.5M, resulting in an average revenue estimate of $4.75M. In the same quarter a year ago, actual revenue was $4k, up 118,650.00% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $6.75M in the next fiscal year. The high estimate is $8.5M and the low estimate is $5M. The average revenue growth estimate for next year is up 42.10% from the average revenue estimate for this year.
